undefined
EUTM file information

018849301

SIMEVIN


March 15, 2023

Trademark Summary

The trademark application SIMEVIN was filed by UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A., a corporation established under the laws of the Hellenic Republic (the "Applicant"). The application was published for oppositions on April 2, 2023, and it was registered by office on July 27, 2023 without any oppositions.

The application was filed in Greek (English was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with "Pharmaceuticals containing the active substances sitagliptin and metformin hydrochloride and indicated for adult patients with type 2 diabetes mellitus.